Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 289 to 294 of 294 entries
Sorted by: Best Match Show Resources per page
The influence of personal values and patient intoxication on nurses concerns about opioids: results of a prospective cross-sectional multi-centre study.

British journal of pain

Heckroth A, Pludra V, Johannssen C, Guest C, Wiedermann F, Bantel C.
PMID: 33628441
Br J Pain. 2021 Feb;15(1):40-53. doi: 10.1177/2049463719880333. Epub 2019 Oct 17.

BACKGROUND: Nurses are the main administrators of opioids in hospitals and enjoy some autonomy when using them to manage pain. Nevertheless evidence suggests they exercise this freedom restrictively with the reasons for this self-limitation remaining unclear. Nurses are influenced...

Cite
Heckroth A, Pludra V, Johannssen C, et al. The influence of personal values and patient intoxication on nurses concerns about opioids: results of a prospective cross-sectional multi-centre study. Br J Pain. 2019;15(1):40-53doi: 10.1177/2049463719880333.
Heckroth, A., Pludra, V., Johannssen, C., Guest, C., Wiedermann, F., & Bantel, C. (2021). The influence of personal values and patient intoxication on nurses concerns about opioids: results of a prospective cross-sectional multi-centre study. British journal of pain, 15(1), 40-53. https://doi.org/10.1177/2049463719880333
Heckroth, Antje, et al. "The influence of personal values and patient intoxication on nurses concerns about opioids: results of a prospective cross-sectional multi-centre study." British journal of pain vol. 15,1 (2021): 40-53. doi: https://doi.org/10.1177/2049463719880333
Heckroth A, Pludra V, Johannssen C, Guest C, Wiedermann F, Bantel C. The influence of personal values and patient intoxication on nurses concerns about opioids: results of a prospective cross-sectional multi-centre study. Br J Pain. 2021 Feb;15(1):40-53. doi: 10.1177/2049463719880333. Epub 2019 Oct 17. PMID: 33628441; PMCID: PMC7882770.
Copy Download .nbib Format: NLM
Increased Serum Levels of Activated Caspases in Murine and Human Biliary Atresia.

Journal of clinical medicine

Madadi-Sanjani O, Bohlen G, Wehrmann F, Andruszkow J, Khelif K, von Wasielewski R, Bantel H, Petersen C.
PMID: 34205476
J Clin Med. 2021 Jun 19;10(12). doi: 10.3390/jcm10122718.

In biliary atresia (BA), apoptosis is part of the pathomechanism, which results in progressive liver fibrosis. There is increasing evidence suggesting that apoptotic liver injury can be non-invasively detected by measuring the caspase activity in the serum. The purpose...

Cite
Madadi-Sanjani O, Bohlen G, Wehrmann F, et al. Increased Serum Levels of Activated Caspases in Murine and Human Biliary Atresia. J Clin Med. 2021;10(12)doi: 10.3390/jcm10122718.
Madadi-Sanjani, O., Bohlen, G., Wehrmann, F., Andruszkow, J., Khelif, K., von Wasielewski, R., Bantel, H., & Petersen, C. (2021). Increased Serum Levels of Activated Caspases in Murine and Human Biliary Atresia. Journal of clinical medicine, 10(12), . https://doi.org/10.3390/jcm10122718
Madadi-Sanjani, Omid, et al. "Increased Serum Levels of Activated Caspases in Murine and Human Biliary Atresia." Journal of clinical medicine vol. 10,12 (2021). doi: https://doi.org/10.3390/jcm10122718
Madadi-Sanjani O, Bohlen G, Wehrmann F, Andruszkow J, Khelif K, von Wasielewski R, Bantel H, Petersen C. Increased Serum Levels of Activated Caspases in Murine and Human Biliary Atresia. J Clin Med. 2021 Jun 19;10(12). doi: 10.3390/jcm10122718. PMID: 34205476; PMCID: PMC8234421.
Copy Download .nbib Format: NLM
Practice report: an Alberta Métis model for COVID-19 vaccine delivery.

Canadian journal of public health = Revue canadienne de sante publique

King KD, Bartel R, James A, MacDonald SE.
PMID: 34988925
Can J Public Health. 2022 Jan 05; doi: 10.17269/s41997-021-00603-7. Epub 2022 Jan 05.

SETTING: In January 2021, the COVID-19 vaccine became available to First Nations, Métis, and Inuit (FNMI) over the age of 65 living in First Nations communities or Métis settlements in Alberta. In March, vaccine eligibility in Alberta expanded to...

Cite
King KD, Bartel R, James A, et al. Practice report: an Alberta Métis model for COVID-19 vaccine delivery. Can J Public Health. 2022;doi: 10.17269/s41997-021-00603-7.
King, K. D., Bartel, R., James, A., & MacDonald, S. E. (2022). Practice report: an Alberta Métis model for COVID-19 vaccine delivery. Canadian journal of public health = Revue canadienne de sante publique, . https://doi.org/10.17269/s41997-021-00603-7
King, Keith D, et al. "Practice report: an Alberta Métis model for COVID-19 vaccine delivery." Canadian journal of public health = Revue canadienne de sante publique vol. (2022). doi: https://doi.org/10.17269/s41997-021-00603-7
King KD, Bartel R, James A, MacDonald SE. Practice report: an Alberta Métis model for COVID-19 vaccine delivery. Can J Public Health. 2022 Jan 05; doi: 10.17269/s41997-021-00603-7. Epub 2022 Jan 05. PMID: 34988925; PMCID: PMC8730752.
Copy Download .nbib Format: NLM
Van der Pauw device used to investigate the thermoelectric power factor.

The Review of scientific instruments

Haupt S, Edler F, Bartel M, Pernau HF.
PMID: 33261461
Rev Sci Instrum. 2020 Nov 01;91(11):115102. doi: 10.1063/5.0019005.

In this paper, we describe a measuring system based on the Van der Pauw principle with four calibrated type S thermocouples. By means of this system, we conducted traceable measurements of the absolute Seebeck coefficients and the electrical conductivity...

Cite
Haupt S, Edler F, Bartel M, et al. Van der Pauw device used to investigate the thermoelectric power factor. Rev Sci Instrum. 2020;91(11):115102doi: 10.1063/5.0019005.
Haupt, S., Edler, F., Bartel, M., & Pernau, H. F. (2020). Van der Pauw device used to investigate the thermoelectric power factor. The Review of scientific instruments, 91(11), 115102. https://doi.org/10.1063/5.0019005
Haupt, Sebastian, et al. "Van der Pauw device used to investigate the thermoelectric power factor." The Review of scientific instruments vol. 91,11 (2020): 115102. doi: https://doi.org/10.1063/5.0019005
Haupt S, Edler F, Bartel M, Pernau HF. Van der Pauw device used to investigate the thermoelectric power factor. Rev Sci Instrum. 2020 Nov 01;91(11):115102. doi: 10.1063/5.0019005. PMID: 33261461.
Copy Download .nbib Format: NLM
Formulation Development of Sublingual Cyclobenzaprine Tablets Empowered by Standardized and Physiologically Relevant Ex Vivo Permeation Studies.

Pharmaceutics

Majid H, Puzik A, Maier T, Merk R, Bartel A, Mueller HC, Burckhardt BB.
PMID: 34575485
Pharmaceutics. 2021 Sep 06;13(9). doi: 10.3390/pharmaceutics13091409.

Suitable ex vivo models are required as predictive tools of oromucosal permeability between in vitro characterizations and in vivo studies in order to support the development of novel intraoral formulations. To counter a lack of clinical relevance and observed...

Cite
Majid H, Puzik A, Maier T, et al. Formulation Development of Sublingual Cyclobenzaprine Tablets Empowered by Standardized and Physiologically Relevant Ex Vivo Permeation Studies. Pharmaceutics. 2021;13(9)doi: 10.3390/pharmaceutics13091409.
Majid, H., Puzik, A., Maier, T., Merk, R., Bartel, A., Mueller, H. C., & Burckhardt, B. B. (2021). Formulation Development of Sublingual Cyclobenzaprine Tablets Empowered by Standardized and Physiologically Relevant Ex Vivo Permeation Studies. Pharmaceutics, 13(9), . https://doi.org/10.3390/pharmaceutics13091409
Majid, Haidara, et al. "Formulation Development of Sublingual Cyclobenzaprine Tablets Empowered by Standardized and Physiologically Relevant Ex Vivo Permeation Studies." Pharmaceutics vol. 13,9 (2021). doi: https://doi.org/10.3390/pharmaceutics13091409
Majid H, Puzik A, Maier T, Merk R, Bartel A, Mueller HC, Burckhardt BB. Formulation Development of Sublingual Cyclobenzaprine Tablets Empowered by Standardized and Physiologically Relevant Ex Vivo Permeation Studies. Pharmaceutics. 2021 Sep 06;13(9). doi: 10.3390/pharmaceutics13091409. PMID: 34575485; PMCID: PMC8472530.
Copy Download .nbib Format: NLM
Role of Mineralocorticoid and Angiotensin Type 1 Receptors in the Paraventricular Nucleus in Angiotensin-Induced Hypertension.

Frontiers in physiology

Burke SL, Barzel B, Jackson KL, Gueguen C, Young MJ, Head GA.
PMID: 33762970
Front Physiol. 2021 Mar 08;12:640373. doi: 10.3389/fphys.2021.640373. eCollection 2021.

The hypothalamic paraventricular nucleus (PVN) is an important site where an interaction between circulating angiotensin (Ang) and mineralocorticoid receptor (MR) activity may modify sympathetic nerve activity (SNA) to influence long-term elevation of blood pressure. We examined in conscious Ang...

Cite
Burke SL, Barzel B, Jackson KL, et al. Role of Mineralocorticoid and Angiotensin Type 1 Receptors in the Paraventricular Nucleus in Angiotensin-Induced Hypertension. Front Physiol. 2021;12:640373doi: 10.3389/fphys.2021.640373.
Burke, S. L., Barzel, B., Jackson, K. L., Gueguen, C., Young, M. J., & Head, G. A. (2021). Role of Mineralocorticoid and Angiotensin Type 1 Receptors in the Paraventricular Nucleus in Angiotensin-Induced Hypertension. Frontiers in physiology, 12640373. https://doi.org/10.3389/fphys.2021.640373
Burke, Sandra L, et al. "Role of Mineralocorticoid and Angiotensin Type 1 Receptors in the Paraventricular Nucleus in Angiotensin-Induced Hypertension." Frontiers in physiology vol. 12 (2021): 640373. doi: https://doi.org/10.3389/fphys.2021.640373
Burke SL, Barzel B, Jackson KL, Gueguen C, Young MJ, Head GA. Role of Mineralocorticoid and Angiotensin Type 1 Receptors in the Paraventricular Nucleus in Angiotensin-Induced Hypertension. Front Physiol. 2021 Mar 08;12:640373. doi: 10.3389/fphys.2021.640373. eCollection 2021. PMID: 33762970; PMCID: PMC7982587.
Copy Download .nbib Format: NLM
Showing 289 to 294 of 294 entries